Establishment of the fingerprint of ganoderma lucidum spore powder and study on the anti-inflammatory activity of ganoderma lucidum spore oil

[Objective] Establishment of a fingerprinting assay for Ganoderma lucidum spore powder and investigation of the effects of Ganoderma lucidum spore oil on the inflammatory factors IL-1β, IL-6, and TNF-α. [Methods] High Performance Liquid Chromatography and High Performance Thin-layer Chromatography t...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu Zhang, Lihui Hou, Le Wang, Yunshan Si, Hongjuan Wen, Ying Gao, Xiuhua Yu
Format: Article
Language:zho
Published: Editorial Office of International Journal of Geriatrics 2025-01-01
Series:Guoji laonian yixue zazhi
Subjects:
Online Access:http://gwll.publish.founderss.cn/thesisDetails#10.3969/j.issn.1674-7593.2025.01.016&lang=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832592764422848512
author Yu Zhang
Lihui Hou
Le Wang
Yunshan Si
Hongjuan Wen
Ying Gao
Xiuhua Yu
author_facet Yu Zhang
Lihui Hou
Le Wang
Yunshan Si
Hongjuan Wen
Ying Gao
Xiuhua Yu
author_sort Yu Zhang
collection DOAJ
description [Objective] Establishment of a fingerprinting assay for Ganoderma lucidum spore powder and investigation of the effects of Ganoderma lucidum spore oil on the inflammatory factors IL-1β, IL-6, and TNF-α. [Methods] High Performance Liquid Chromatography and High Performance Thin-layer Chromatography techniques were used to analyze the chemical composition of Ganoderma lucidum spore powder from different origins; MTT method was used to determine the cell viability; ELISA was used to determine the RAW264.7 IL-1β, IL-6 and TNF-α levels in cell supernatant. [Results] The HPLC fingerprints were calibrated with a total of 12 peaks, of which peaks 1-5 were ganoderic acid C2, ganoderic acid G, ganoderic acid B, ganoderic acid A, ganoderic acid D, respectively; the current version of the Pharmacopoeia method of HPTLC showed that 10 batches of samples complied with the regulations, and the quality of raw materials of different origins was found to be similar to that of the HPLC fingerprints after 2 unfoldings by using trichloromethane-acetonitrile-methanol-formic acid (26∶4 ∶1∶1) as the unfolding agent. The differences of the spots were significant and similar to the HPLC fingerprints. Ganoderma lucidum spore oil concentration less than or equal to 180 μg/mL had no significant effect on the activity of RAW264.7 cells; the protective effect on LPS-induced RAW264.7 cells was dose-dependent; compared with the model group, the medium-dose group (90 μg/mL) significantly decreased the expression of IL-1β (P<0.05), and the high-dose group (180 μg/mL) significantly decreased the expression of IL-6 and TNF-α release (P<0.05), slightly reduced IL-1β release, but not significant (P>0.05). [Conclusion] Ganoderma lucidum spore oil is used to reduce the inflammation of the body by inhibiting the release of inflammatory factors to achieve the protective effect on immune cells. The quality of spore powder can be initially identified by HPTLC, and HPLC fingerprinting can accurately control the quality of raw materials and guarantee the efficacy of Ganoderma lucidum spore oil.
format Article
id doaj-art-0975e31e5b4f46d59484d4fb00ad00f8
institution Kabale University
issn 1674-7593
language zho
publishDate 2025-01-01
publisher Editorial Office of International Journal of Geriatrics
record_format Article
series Guoji laonian yixue zazhi
spelling doaj-art-0975e31e5b4f46d59484d4fb00ad00f82025-01-21T02:59:39ZzhoEditorial Office of International Journal of GeriatricsGuoji laonian yixue zazhi1674-75932025-01-01461788410.3969/j.issn.1674-7593.2025.01.016Establishment of the fingerprint of ganoderma lucidum spore powder and study on the anti-inflammatory activity of ganoderma lucidum spore oilYu Zhang0Lihui Hou1Le Wang2Yunshan Si3Hongjuan Wen4Ying Gao5Xiuhua Yu6School of Pharmacy, Changchun University of Traditional Chinese Medicine, Changchun 130117School of Pharmacy, Changchun University of Traditional Chinese Medicine, Changchun 130117School of Pharmacy, Changchun University of Traditional Chinese Medicine, Changchun 130117Jilin Academy of Chinese Medicine Sciences, Changchun 130000School of Health Management, Changchun University of Traditional Chinese Medicine, Changchun 130000The 964th Hospital of the Joint Logistics Support Force of the People’s Liberation Army of China, Changchun 130012Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun 130021[Objective] Establishment of a fingerprinting assay for Ganoderma lucidum spore powder and investigation of the effects of Ganoderma lucidum spore oil on the inflammatory factors IL-1β, IL-6, and TNF-α. [Methods] High Performance Liquid Chromatography and High Performance Thin-layer Chromatography techniques were used to analyze the chemical composition of Ganoderma lucidum spore powder from different origins; MTT method was used to determine the cell viability; ELISA was used to determine the RAW264.7 IL-1β, IL-6 and TNF-α levels in cell supernatant. [Results] The HPLC fingerprints were calibrated with a total of 12 peaks, of which peaks 1-5 were ganoderic acid C2, ganoderic acid G, ganoderic acid B, ganoderic acid A, ganoderic acid D, respectively; the current version of the Pharmacopoeia method of HPTLC showed that 10 batches of samples complied with the regulations, and the quality of raw materials of different origins was found to be similar to that of the HPLC fingerprints after 2 unfoldings by using trichloromethane-acetonitrile-methanol-formic acid (26∶4 ∶1∶1) as the unfolding agent. The differences of the spots were significant and similar to the HPLC fingerprints. Ganoderma lucidum spore oil concentration less than or equal to 180 μg/mL had no significant effect on the activity of RAW264.7 cells; the protective effect on LPS-induced RAW264.7 cells was dose-dependent; compared with the model group, the medium-dose group (90 μg/mL) significantly decreased the expression of IL-1β (P<0.05), and the high-dose group (180 μg/mL) significantly decreased the expression of IL-6 and TNF-α release (P<0.05), slightly reduced IL-1β release, but not significant (P>0.05). [Conclusion] Ganoderma lucidum spore oil is used to reduce the inflammation of the body by inhibiting the release of inflammatory factors to achieve the protective effect on immune cells. The quality of spore powder can be initially identified by HPTLC, and HPLC fingerprinting can accurately control the quality of raw materials and guarantee the efficacy of Ganoderma lucidum spore oil.http://gwll.publish.founderss.cn/thesisDetails#10.3969/j.issn.1674-7593.2025.01.016&lang=enganoderma lucidum spore oilhplc fingerprintinghptlcil-1βil-6tnf-α
spellingShingle Yu Zhang
Lihui Hou
Le Wang
Yunshan Si
Hongjuan Wen
Ying Gao
Xiuhua Yu
Establishment of the fingerprint of ganoderma lucidum spore powder and study on the anti-inflammatory activity of ganoderma lucidum spore oil
Guoji laonian yixue zazhi
ganoderma lucidum spore oil
hplc fingerprinting
hptlc
il-1β
il-6
tnf-α
title Establishment of the fingerprint of ganoderma lucidum spore powder and study on the anti-inflammatory activity of ganoderma lucidum spore oil
title_full Establishment of the fingerprint of ganoderma lucidum spore powder and study on the anti-inflammatory activity of ganoderma lucidum spore oil
title_fullStr Establishment of the fingerprint of ganoderma lucidum spore powder and study on the anti-inflammatory activity of ganoderma lucidum spore oil
title_full_unstemmed Establishment of the fingerprint of ganoderma lucidum spore powder and study on the anti-inflammatory activity of ganoderma lucidum spore oil
title_short Establishment of the fingerprint of ganoderma lucidum spore powder and study on the anti-inflammatory activity of ganoderma lucidum spore oil
title_sort establishment of the fingerprint of ganoderma lucidum spore powder and study on the anti inflammatory activity of ganoderma lucidum spore oil
topic ganoderma lucidum spore oil
hplc fingerprinting
hptlc
il-1β
il-6
tnf-α
url http://gwll.publish.founderss.cn/thesisDetails#10.3969/j.issn.1674-7593.2025.01.016&lang=en
work_keys_str_mv AT yuzhang establishmentofthefingerprintofganodermalucidumsporepowderandstudyontheantiinflammatoryactivityofganodermalucidumsporeoil
AT lihuihou establishmentofthefingerprintofganodermalucidumsporepowderandstudyontheantiinflammatoryactivityofganodermalucidumsporeoil
AT lewang establishmentofthefingerprintofganodermalucidumsporepowderandstudyontheantiinflammatoryactivityofganodermalucidumsporeoil
AT yunshansi establishmentofthefingerprintofganodermalucidumsporepowderandstudyontheantiinflammatoryactivityofganodermalucidumsporeoil
AT hongjuanwen establishmentofthefingerprintofganodermalucidumsporepowderandstudyontheantiinflammatoryactivityofganodermalucidumsporeoil
AT yinggao establishmentofthefingerprintofganodermalucidumsporepowderandstudyontheantiinflammatoryactivityofganodermalucidumsporeoil
AT xiuhuayu establishmentofthefingerprintofganodermalucidumsporepowderandstudyontheantiinflammatoryactivityofganodermalucidumsporeoil